Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N0IC
|
|||
| Former ID |
DNC009899
|
|||
| Drug Name |
N-(3,5-dichlorophenyl)-4-methoxy-3-nitrobenzamide
|
|||
| Synonyms |
N-(3,5-dichlorophenyl)-4-methoxy-3-nitrobenzamide; CHEMBL560684; AC1LEFV7; AC1Q44SN; MolPort-001-508-011; ZINC103353; STK082881; BDBM50297552; AKOS003266964; MCULE-2399924405; ST011242; AG-690/12072790; N-(3,5-dichlorophenyl)-3-nitro-4-(methyloxy)benzamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H10Cl2N2O4
|
|||
| Canonical SMILES |
COC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)Cl)Cl)[N+](=O)[O-]
|
|||
| InChI |
1S/C14H10Cl2N2O4/c1-22-13-3-2-8(4-12(13)18(20)21)14(19)17-11-6-9(15)5-10(16)7-11/h2-7H,1H3,(H,17,19)
|
|||
| InChIKey |
BDZYJQMEFCDSIR-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bacterial Fatty acid synthetase I (Bact inhA) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening. Eur J Med Chem. 2009 Sep;44(9):3718-30. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.